Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Prazosin HCl Capsules from Two Manufacturing Sites
NCT07231978Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of prazosin in hypertension (HTN) and heart failure (HF) (2 cohorts), sponsored by Pfizer. Primary endpoints: Area under the plasma concentration-time curve and Maximum plasma concentration. Started Nov 2025; status: completed.
02
Drugs
prazosin
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT07231978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07231978.